Trial NCT03093831

View at ClinicalTrials.gov 
Org. Study IDs: 54179060LYM2009

Last trial update was posted on 2023-10-11

MeSH Interventions

Ibrutinib

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, B-Cell, Marginal Zone

Other Conditions


Stopping Reasons

Study did not meet the objectives and terminated early on 17 Jul 2020 due to poor recruitment

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID